TCI Wealth Advisors, Inc. - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 62 filers reported holding GALECTIN THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is 2.26 and the average weighting 0.0%.

Quarter-by-quarter ownership
TCI Wealth Advisors, Inc. ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$1,0000.0%3000.0%0.00%
Q2 2021$1,0000.0%3000.0%0.00%
Q1 2021$1,0000.0%3000.0%0.00%
Q4 2020$1,0000.0%3000.0%0.00%
Q3 2020$1,0000.0%3000.0%0.00%
Q2 2020$1,0000.0%3000.0%0.00%
Q1 2020$1,0000.0%3000.0%0.00%
Q4 2019$1,0000.0%3000.0%0.00%
Q3 2019$1,0000.0%3000.0%0.00%
Q2 2019$1,000
-50.0%
3000.0%0.00%
-100.0%
Q1 2019$2,000
+100.0%
3000.0%0.00%
Q4 2018$1,000
-50.0%
3000.0%0.00%
-100.0%
Q3 2018$2,0000.0%3000.0%0.00%0.0%
Q2 2018$2,000
+100.0%
3000.0%0.00%
Q1 2018$1,0000.0%3000.0%0.00%
Q4 2017$1,0000.0%3000.0%0.00%
Q3 2017$1,0000.0%3000.0%0.00%
-100.0%
Q2 2017$1,0000.0%3000.0%0.00%0.0%
Q1 2017$1,0003000.0%0.00%
Q4 2016$03000.0%0.00%
Q3 2016$03000.0%0.00%
Q2 2016$03000.0%0.00%
Q1 2016$03000.0%0.00%
Q4 2015$0
-100.0%
3000.0%0.00%
-100.0%
Q3 2015$1,0000.0%3000.0%0.00%0.0%
Q2 2015$1,0000.0%3000.0%0.00%0.0%
Q1 2015$1,0000.0%3000.0%0.00%0.0%
Q4 2014$1,000
-50.0%
3000.0%0.00%0.0%
Q3 2014$2,000
-50.0%
3000.0%0.00%
-50.0%
Q2 2014$4,000
-20.0%
3000.0%0.00%
-33.3%
Q1 2014$5,0003000.00%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q1 2015
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 169,578$276,0000.10%
Geneos Wealth Management Inc. 445,200$725,0000.05%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$20,0000.01%
Vivaldi Capital Management LP 19,261$30,0000.01%
Atria Wealth Solutions, Inc. 278,700$454,2810.01%
OSAIC HOLDINGS, INC. 1,302,122$2,123,0000.01%
BARRETT & COMPANY, INC. 4,984$5,6320.00%
Ameritas Advisory Services, LLC 45,302$74,0000.00%
CENTAURUS FINANCIAL, INC. 20,732$34,0000.00%
BENJAMIN F. EDWARDS & COMPANY, INC. 19,255$31,0000.00%
View complete list of GALECTIN THERAPEUTICS INC shareholders